4//SEC Filing
Hardy Nathan 4
Accession 0001562180-23-002395
CIK 0001770121other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:34 PM ET
Size
9.4 KB
Accession
0001562180-23-002395
Insider Transaction Report
Form 4
Hardy Nathan
SVP, Chief Financial Officer
Transactions
- Award
Stock Options (Right to Buy)
2023-03-02+200,000→ 200,000 totalExercise: $3.76Exp: 2033-03-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on March 2, 2024 and in 36 equal monthly installments thereafter.
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001830053
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:34 PM ET
- Size
- 9.4 KB